MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 97.89 7.69 9.00 14.95 22.46 16.55 26.83 31.12 27.82
Piotroski F-Score
4 6 7 5 6 8 7 7 6 7
P/S ratio
0.30 0.32 0.71 0.81 1.61 2.47 1.81 2.98 2.87 1.81
Altman Z-Score
4.46 5.22 10.15 12.72 14.21 17.98 15.50 20.85 18.06 16.57
Altman Z″-Score (non-manufacturers)
10.15 8.54 9.32 8.08 8.55 9.40 9.71 10.46 11.15 12.16
P/FCF ratio
0.00 0.00 6.69 8.54 73.46 20.57 27.31 51.31 65.95 0.00
P/Operating CF
(22.22) (38.93) 72.65 24.90 (328.65) 116.55 67.35 97.38 86.61 (1,579.31)
Beneish M-Score
— — — — — — (1.46) (1.83) 0.35 (3.05)
Dividend Safety Score
57 — — — — — — — — —
P/B ratio
0.59 0.92 3.79 8.31 12.11 14.70 12.30 13.69 7.96 5.18
Price to Tangible BV
0.59 0.92 3.79 8.31 12.11 14.70 12.30 13.69 7.96 5.18
EV/Sales
(0.03) 0.11 0.61 0.78 1.56 2.30 1.70 2.78 2.54 1.53
EV/EBITDA
17.88 4.65 4.72 6.37 10.64 15.47 12.60 18.81 17.20 12.87
EV/Operating CF
(1.67) 2.81 4.45 6.41 25.11 14.79 14.37 22.90 17.72 16.60
EV/FCF
0.45 (6.92) 5.76 8.27 71.15 19.12 25.63 47.85 58.43 (110.33)
Quick Ratio
3.89 2.53 1.63 0.62 0.65 1.57 1.19 1.69 2.68 3.20
Current Ratio
4.69 3.34 2.43 1.58 1.81 2.10 1.94 2.41 3.37 4.15
Net Debt/EBITDA
260.55 (10.98) (1.08) (0.45) (0.49) (1.26) (0.96) (1.36) (2.22) (2.35)
Debt/Assets
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover
1.45 2.03 3.42 4.47 4.53 3.97 3.92 3.18 2.26 2.31
Operating CF/Net income
(0.37) 11.71 1.49 1.36 0.58 1.41 1.08 1.09 1.56 1.42
Capex/Depreciation
(0.41) (0.63) (0.50) (1.52) (4.96) (1.27) (1.98) (0.95) (0.64) (4.93)
Interest Coverage
— — — 263.63 936.11 (545.36) 91.04 69.06 39.63 94.91
ROE
(9.13%) 1.02% 55.77% 80.31% 91.20% 78.49% 72.84% 51.26% 27.10% 19.32%
ROA
(7.02%) 0.70% 31.76% 40.18% 48.64% 43.70% 42.80% 35.38% 20.75% 15.03%
ROIC
(28.07%) 3.77% 153.58% 171.49% 145.43% 0.00% 468.15% 534.74% 254.13% 87.58%
Return on Tangible Assets
(9.83%) 1.11% 54.27% 103.23% 84.92% 68.30% 77.30% 53.16% 25.99% 18.46%
Average Days of Receivables
0.00 0.00 0.00 0.00 0.00 0.00 0.73 0.74 0.70 1.84
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
75.02% 73.32% 60.58% 59.78% 59.72% 60.29% 62.47% 62.04% 62.40% 65.13%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
1.98% 1.22% 0.76% 0.69% 0.65% 0.73% 0.63% 0.62% 1.41% 1.25%
Graham Net Nets
1.30 0.73 0.15 0.05 0.05 0.05 0.05 0.06 0.10 0.15
Graham Number
0.00 8.82 61.67 63.13 73.84 51.25 36.42 30.94 21.85 16.60
Earnings Yield
(15.92%) 1.02% 13.00% 11.11% 6.69% 4.45% 6.04% 3.73% 3.21% 3.59%
Free Cash Flow Yield
(21.93%) (5.16%) 14.94% 11.71% 1.36% 4.86% 3.66% 1.95% 1.52% (0.77%)
Revenue per Share
35.13 55.12 98.50 142.79 130.38 79.42 60.63 41.94 25.29 23.18
Operating CF per Share
0.63 2.24 13.57 17.38 8.08 12.34 7.16 5.09 3.63 2.14
Capex per Share
(0.51) (0.68) (0.60) (1.49) (2.92) (0.50) (0.85) (0.40) (0.27) (2.43)
Free Cash Flow per Share
0.11 1.56 12.97 15.89 5.15 11.83 6.30 4.69 3.36 (0.29)
Cash per Share
15.23 14.85 13.79 7.83 9.36 14.82 7.87 8.46 8.29 6.49
Shareholders Equity per Share
18.11 19.22 18.51 13.85 17.30 13.36 8.91 9.13 9.11 8.11
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
18.11 19.22 18.51 13.85 17.30 13.36 8.91 9.13 9.11 8.11
Free Cash Flow
1.25 17.02 141.17 177.89 60.34 139.31 74.20 56.07 40.08 (3.43)
Working Capital
158.72 150.24 131.73 81.89 137.03 122.96 74.76 85.20 88.06 76.88
Capital Expenditures
(5.61) (7.45) (6.48) (16.68) (34.21) (5.89) (10.06) (4.74) (3.16) (28.78)
Net Current Asset Value
152.63 140.30 115.60 61.62 111.01 115.48 64.33 85.20 87.85 76.10
EV/EBIT
0.81 23.89 5.20 6.75 10.98 16.01 13.30 20.17 19.33 15.67
Capex to Sales
0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.10
Price to Operating Income
0.00 66.92 6.05 6.97 11.34 17.23 14.17 21.63 21.82 18.52
Other line items
Depreciation/Fixed assets
0.43 0.32 0.25 0.19 0.12 0.17 0.20 0.25 0.26 0.30
Cash ROIC
0.34% 4.57% 40.16% 73.29% 19.34% 42.00% 37.57% 26.68% 19.32% (1.98%)
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 925.13 583.07 631.38 307.25 181.81
Accounts Payable Turnover
2.33 2.21 2.68 3.07 2.94 2.58 2.59 2.49 2.40 2.94
Inventory Turnover
3.53 3.25 3.42 3.07 3.41 4.64 4.03 4.16 3.92 4.35
Average Days of Payables
126.59 130.64 106.49 107.30 149.58 165.81 157.34 181.81 183.81 128.79
Days of Inventory on Hand
66.76 98.10 67.27 94.69 164.91 82.22 100.68 117.21 95.66 97.05
Average Receivables
— — — — — 1.01 1.22 0.79 0.98 1.51
Average Payables
47.43 71.45 110.55 149.00 135.49 91.95 68.27 48.73 30.72 23.40
Average Inventory
31.32 48.51 86.72 149.45 116.72 51.08 43.83 29.11 18.82 15.82
Average Assets
266.09 297.06 313.06 357.27 337.21 235.37 182.04 157.68 133.57 118.67
Average Common Equity
204.51 205.80 178.26 178.76 179.86 131.04 106.97 108.84 102.30 92.30

Fold the line items

Columns are period end dates